Key Takeaways Here's how to find the best top-ranked value stocks to buy in 2026.Healthcare stock BTSG soared 230% since its 2024 IPO. Yet it's a great value stock with big growth potential.No matter what happens in the next few weeks, the bull case for Wall Street remains intact for 2026. Investors should be optimistic heading into next year because earnings are projected to grow significantly, and the Fed is expected to keep lowering interest rates.That said, some investors might not want to chase technol ...

Core Insights - BrightSpring Health Services reported strong financial results for Q3 2025, with total revenue reaching $3,334 million, a 28% increase from $2,601 million in Q3 2024 [4][3] - The company has increased its revenue guidance for 2025, projecting revenues between $12,500 million and $12,800 million, representing a growth of 24.1% to 27.1% compared to 2024 [4][3] - Adjusted EBITDA for Q3 2025 was $160 million, up 37.2% from $117 million in Q3 2024, indicating strong operational performance [4][3] Financial Performance - Pharmacy Solutions revenue for Q3 2025 was $2,967 million, a 31% increase from $2,266 million in Q3 2024, while Provider Services revenue increased by 9% to $367 million [3][4] - Gross profit for Q3 2025 was $392 million, up 21.3% from $323 million in Q3 2024, reflecting improved cost management [4][3] - The net income for Q3 2025 was $37.5 million, a significant turnaround from a net loss of $25.7 million in Q3 2024 [4][3] Business Metrics - The company dispensed 10,793,219 prescriptions in Q3 2025, a slight decrease of 1% from 10,874,429 in Q3 2024, but revenue per script increased by 32% to $274.89 [6][4] - The average daily census for Home Health Care increased by 3% to 29,592 in Q3 2025 compared to 28,650 in Q3 2024 [6][4] - The number of Rehab Care persons served rose by 11% to 7,321 in Q3 2025, indicating growth in service demand [6][4] Strategic Developments - The planned divestiture of the Community Living business to Sevita is expected to close in Q1 2026, which may impact future financial results [4][3] - The company has repurchased 1,500,000 shares as part of a secondary offering, indicating confidence in its stock value [4][3] - BrightSpring continues to focus on delivering high-quality, patient-centric care while leveraging its scale to improve operational efficiency [2][3]

Core Viewpoint - BrightSpring Health Services, Inc. is conducting a secondary offering of 15,000,000 shares of common stock, with no shares being sold by the company itself, and the proceeds will go entirely to the selling stockholders [1] Group 1: Offering Details - The offering is expected to close on October 22, 2025, subject to customary closing conditions [1] - The company has authorized the concurrent purchase of 1,500,000 shares from the underwriter at the same price per share as the offering, with the repurchase closing simultaneously with the offering [2] - BofA Securities is acting as the sole book-running manager for the offering, which will be sold at market prices or negotiated prices [3] Group 2: Regulatory Information - A shelf registration statement relating to these securities was filed with the SEC on June 10, 2025, and became effective upon filing [4] - The offering will be made only by means of a prospectus supplement and accompanying prospectus [5]

Core Viewpoint - BrightSpring Health Services, Inc. announced a secondary offering of 15,000,000 shares of common stock by certain stockholders, with no shares being sold by the company itself [1] Group 1: Offering Details - The secondary offering will be conducted by selling stockholders, including an affiliate of Kohlberg Kravis Roberts & Co. L.P. and certain management members [1] - The company has authorized a concurrent share repurchase of up to 10% of the shares sold in the offering or $50 million, whichever is less, at the same price per share as the underwriter [2] - BofA Securities is acting as the sole book-running manager for the offering, which will be sold at market prices or negotiated prices [3] Group 2: Regulatory and Documentation - A shelf registration statement related to these securities was filed with the SEC on June 10, 2025, and became effective upon filing [4] - The offering will be made only by means of a preliminary prospectus supplement and accompanying prospectus, which can be obtained from BofA Securities [5]

Core Insights - BrightSpring Health Services, Inc. reported preliminary financial results for Q3 2025, showing significant revenue growth and improved Adjusted EBITDA guidance [1][2][5] Financial Performance - Total revenue for Q3 2025 reached approximately $3,334 million, a 28.2% increase from $2,601 million in Q3 2024 [5][4] - Gross profit for Q3 2025 was approximately $392 million, up 21.3% from $323 million in Q3 2024 [5][4] - The company achieved a net income of approximately $37.5 million in Q3 2025, compared to a net loss of approximately $25.7 million in Q3 2024 [5][4] - Adjusted EBITDA for Q3 2025 was approximately $160 million, reflecting a 37.2% increase from $117 million in Q3 2024 [5][4] Segment Performance - Pharmacy Solutions revenue for Q3 2025 was $2,967 million, a 31% increase from $2,266 million in Q3 2024 [4][5] - Provider Services revenue for Q3 2025 was $367 million, a 9% increase from $336 million in Q3 2024 [4][5] - Total Adjusted EBITDA for the company was $202 million for Q3 2025, up 33% from $151 million in Q3 2024 [6][5] Future Guidance - The company increased its 2025 revenue guidance to between $12,400 million and $12,700 million, representing a growth of 23.1% to 26.1% compared to 2024 [5][4] - Adjusted EBITDA guidance for 2025 is set between $605 million and $615 million, indicating a growth of 31.5% to 33.7% [5][4] Upcoming Events - BrightSpring will announce full Q3 results on October 28, 2025, and will host a conference call at 4:30 p.m. Eastern Time on the same day [3][1]

Core Viewpoint - BrightSpring Health Services, Inc. announced a secondary offering of 14,000,000 shares of common stock by certain stockholders, including affiliates of Kohlberg Kravis Roberts & Co. L.P. [1] Group 1: Offering Details - The offering will be conducted under a shelf registration statement filed with the SEC, and no shares are being sold by BrightSpring itself [1][3] - The KKR Selling Stockholder plans to grant underwriters a 30-day option to purchase an additional 2,100,000 shares [1] - Goldman Sachs & Co. LLC and BofA Securities are the lead book-running managers for the offering, with KKR Capital Markets LLC acting as the lead managing agent [2] Group 2: Registration and Prospectus - A shelf registration statement on Form S-3 was filed with the SEC on June 10, 2025, and became effective upon filing [3] - The offering will be made only by means of a prospectus supplement and accompanying prospectus [4]